The present disclosure relates generally to apparatus and techniques in manufacturing, and more specifically to adhesives used in conjunction with three-dimensional (3-D) printed components for use in producing vehicles, boats, aircraft and other mechanical structures.
Three-dimensional (3-D) printing, which may also be referred to as additive manufacturing, is a process used to create 3-D objects. The 3-D objects may be formed using layers of material based on digital model data of the object. A 3-D printer may form the structure defined by the digital model data by printing the structure one layer at a time. 3-D printed objects may be almost any shape or geometry.
A 3-D printer may disseminate a powder layer (e.g., powdered metal) on an operating surface. The powder layer may be approximately 100 microns thick. The 3-D printer may then bond particular areas of the powder layer into a layer of the object, e.g., by using a laser to bond the powder of the powder layer together. The steps may be repeated to sequentially form each layer. Accordingly, the 3-D printed object may be built layer by layer to form the 3-D object.
3-D printed components may be used to produce sub-components for various devices or apparatus. The 3-D printed sub-components may need to be attached or connected to other sub-components, including other 3-D printed sub-components, extruded sub-components, or still other sub-components.
Several aspects of assembling structures comprising 3D printed components and standardized components utilizing adhesive circuits is presented.
An aspect is an apparatus including a plurality of additively manufactured components each having an adhesive injection channel. The components are connected together such that adhesive injection channels are aligned to form an adhesive path that allows adhesive flow between the components.
Another aspect is a vehicle including a plurality of subassemblies, each of the subassemblies having a plurality of additively manufactured components each having an adhesive injection channel. The components for each of the subassemblies are connected together such that adhesive injection channels are aligned to form an adhesive path that allows adhesive flow between the components. Each of the subassemblies may be connected together such the adhesive path for each of the subassemblies are aligned to allow the adhesive to flow between the subassemblies.
Another aspect is an apparatus, including an additively manufactured component having an adhesive injection channel and an adhesive flow mechanism comprising at least one of an adhesive side end effector or a vacuum side end effector, the adhesive flow mechanism configured to provide adhesive to the adhesive injection channels.
It will be understood that other aspects of adhesives for 3-D printed components and methods of connecting 3-D printed components with adhesives will become readily apparent to those skilled in the art from the following detailed description, wherein it is shown and described only several embodiments by way of illustration. As will be realized by those skilled in the art, the adhesives for 3-D printed components and methods for connecting 3-D printed components with adhesives are capable of other and different embodiments, and its several details are capable of modification in various other respects, all without departing from the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not as restrictive.
Various aspects of using adhesives with 3-D printed components will now be presented in the detailed description by way of example, and not by way of limitation, in the accompanying drawings, wherein:
The detailed description set forth below in connection with the appended drawings is intended to provide a description of various exemplary embodiments of using adhesives with 3-D printed components and is not intended to represent the only embodiments in which the invention may be practiced. The term “exemplary” used throughout this disclosure means “serving as an example, instance, or illustration,” and should not necessarily be construed as preferred or advantageous over other embodiments presented in this disclosure. The detailed description includes specific details for the purpose of providing a thorough and complete disclosure that fully conveys the scope of the invention to those skilled in the art. However, the invention may be practiced without these specific details. In some instances, well-known structures and components may be shown in block diagram form, or omitted entirely, in order to avoid obscuring the various concepts presented throughout this disclosure.
The use of 3-D printing and using adhesives for three-dimensional printed components may provide significant flexibility for enabling manufacturers of mechanical structures and mechanized assemblies to manufacture parts with complex geometries. For example, 3-D printing techniques provide manufacturers with the flexibility to design and build parts having intricate internal lattice structures and/or profiles that are not possible to manufacture via traditional manufacturing processes.
Referring specifically to
In various embodiments, the deflector 105 can include one or more gimbals and actuators that can rotate and/or translate the energy beam source to position the energy beam. In various embodiments, energy beam source 103 and/or deflector 105 can modulate the energy beam, e.g., turn the energy beam on and off as the deflector scans so that the energy beam is applied only in the appropriate areas of the powder layer. For example, in various embodiments, the energy beam can be modulated by a digital signal processor (DSP).
In some aspects, the assembly 202 (or subassembly) may be fixtured using features on the node (e.g., printed node 204). The printed nodes 204 may be printed with a great degree of accuracy. The printed nodes 204 may be fixtured during the assembly process. The other components may float with respect to the printed node 204 during the assembly processes.
Some aspects described herein may use a section-by-section approach. In a section-by-section approach, each component (or section) may be connected together one-by-one. A section-by-section approach may be time-consuming. The assembly 202 of
In an aspect, as illustrated in
In an aspect, different sections may be placed together, e.g., in an assembly fixture (not shown). The different sections (e.g., printed nodes 204, panel 206, extrusions 208) may form a sub-assembly or an entire assembly. For example, the different sections may form a sub-assembly of a vehicle, an entire assembly of a vehicle, or other items that may be 3-D printed or assembled using the systems and methods described herein.
In an aspect, the sub-assembly or assembly may include one or more node-to-node connections, one or more node-to-panel connections, one or more node-to-extrusion connections, one or more extrusion-to-panel connections, or some combination of one or more node-to-node connections, node-to-panel connections, node-to-extrusion connections, extrusion-to-panel connections, or node-to-tube connections (e.g., using printed nodes 204, panel 206, extrusions 208, and/or other nodes, panel, extrusions).
In an aspect, sealants, adhesives, or both, may be applied to the different sections or components (e.g., printed nodes 204, panel 206, extrusions 208) that have been placed together, e.g., in an assembly fixture. Once the interfaces are sufficiently sealed, the entire assembly 202 may be connected to vacuum and adhesive tubes (not shown), e.g., to pull adhesive along the adhesive path 304. In an aspect, sealants may enable a vacuum to be drawn to evacuate the adhesive path. When the path is evacuated, adhesive may be injected. In addition to sealing the adhesive path so as to enable adhesive injection, the sealants may also prevent contact between dissimilar materials. Preventing contact between dissimilar materials may prevent galvanic corrosion. In an aspect, the sealant may be disposed along the adhesive path on both ends. The features for accepting seals may be additively manufactured with a node, or the features for accepting seals may be used on commercial-off-the-shelf parts as well. In an aspect, the sealants may include O-rings. In an aspect, the sealants may ensure that cured adhesive resides in a hermetically sealed environment on completion of an adhesive injection and curing process.
For example, adhesive may be drawn into interfaces (e.g., port 306a, 306b) by the vacuum in a loop (e.g., adhesive path 304 may form a loop), flowing into all the interfacing surfaces between the various connections between the components, (e.g., using printed nodes 204, panel 206, extrusions 208, and/or other nodes, panel, extrusions). Once the adhesive flows into all the interfacing surfaces, the entire assembly 202 may be left to cure. Weep holes may be provided to check for complete fill in the event high-temperature liquid adhesive is used without a vacuum mechanism. Additionally, some aspects of the printed node 204 may include protrusions. The printed node 204 and the protrusions may be 3-D printed. For example, the printed node 204 and any protrusions on the printed node 204 may be co-printed.
For example, an apparatus (e.g., assembly 202) may include a plurality of additively manufactured components (e.g., printed nodes 204) as well as other components in some aspects (e.g., panel 206, extrusions 208). Each additively manufactured component (e.g., printed nodes 204), as well as other components (e.g., panel 206, extrusions 208), may have an adhesive injection channel 302. The components (such as, in some aspects, additively manufactured components, e.g., printed nodes 204 as well as other components, e.g., panel 206, extrusions 208, and the like) may be connected together such that adhesive injection channels 302 are aligned to form an adhesive path 304 that may allow adhesive flow between the components (such as, in some aspects, additively manufactured components, e.g., printed nodes 204 as well as other components, e.g., panel 206, extrusions 208, and the like).
In an aspect, one of the components comprises adhesive ports 306a, 306b for injecting adhesive into the adhesive path 304. In an aspect, each of the components (e.g., printed nodes 204, panel 206, extrusions 208) may include a vacuum channel (similar in structure to adhesive injection channels 302) for drawing a vacuum and inducing the flow of the adhesive. The components (e.g., printed nodes 204, panel 206, extrusions 208) may be connected together such that vacuum channels (e.g., adhesive injection channels 302) may be aligned to form a vacuum path (e.g., adhesive path 304) that allows a vacuum between the components (additively manufactured components, e.g., printed nodes 204 as well as other components, e.g., panel 206, extrusions 208, in some aspects). In an aspect, by connecting the vacuum port (e.g., the adhesive port 306a or 306b) to a vacuum source, the adhesive path may be evacuated. The adhesive inlet port (e.g., the adhesive port 306b or 306a) and adhesive outlet port (e.g., the adhesive port 306a or 306b) (e.g., the vacuum port) are two ends of the adhesive path 304. In an aspect, one of the components may include a dedicated vacuum port for providing a vacuum to the vacuum path (e.g., adhesive path 304).
In an aspect, the components (additively manufactured components, e.g., printed nodes 204 as well as other components, e.g., panel 206, extrusions 208, in some aspects) may include a first subassembly, the apparatus further including a second subassembly and a member interconnecting the first and the second subassemblies. The member may include an adhesive injection channel 302 connecting the adhesive path through the components (additively manufactured components, e.g., printed nodes 204 as well as other components, e.g., panel 206, extrusions 208, in some aspects) to the second subassembly. An aspect may further include adhesive extending along the adhesive path 304.
In an aspect, one or more apertures in each of one or more components in communication with the adhesive path may provide a visual indication of adhesive flow. In an aspect, a first one of the components may include a node 204 connecting a second one of the components (206, 208) to a third one of the components (208, 206). In an aspect, the second one of the components comprises a panel 206. In an aspect, the second one of the components comprises a tube, such as, for example, an extruded tube integrated with extrusion 208. In an aspect, the components may form a subassembly for a vehicle. For example, the assembly 202 may be a subassembly of a vehicle. The components may be a subassembly for a vehicle chassis. In another aspect, the components may be a subassembly for a vehicle body.
Referring still to
One aspect is a vehicle (e.g., assembly 202) including a plurality of subassemblies (e.g., printed nodes 204, panel 206, extrusions 208). In an aspect, each of the subassemblies (e.g., printed nodes 204) may have a plurality of additively manufactured components. Each of the additively manufactured components (e.g., printed nodes 204) may have an adhesive injection channel similar to adhesive injection channel 302. The components for each of the subassemblies (e.g., printed nodes 204, panel 206, extrusions 208) may be connected together such that adhesive injection channels (e.g., adhesive injection channel 302) are aligned to form an adhesive path 304 that allows substantially unimpeded adhesive flow between the components. Additionally, each of the subassemblies may be connected together such that the adhesive path for each of the subassemblies may be aligned to allow adhesive to flow between the subassemblies.
The example of
Some examples implementations of
A vacuum in the adhesive path 304 may be developed using a vacuum port or multiple vacuum ports. The number of vacuum ports may be based on one or more of the size of the assembly, the length of the adhesive path 304, the shape of the adhesive path 304, the timing desired for the addition of adhesive, or other factors of adding adhesive to the adhesive path 304 or factors of the design, such as availability of locations on the assembly for adhesive ports or vacuum ports.
In an aspect, larger assemblies may have a greater number of adhesive paths 304, longer adhesive paths 304, or both. Adding adhesive to a greater number of adhesive paths and/or longer adhesive paths may take longer. Accordingly, additional vacuum ports and/or more adhesive ports may be used for assemblies having long adhesive paths, a large number of adhesive paths or both, depending on the timing desired for the addition of adhesive. Conversely, assemblies having fewer adhesive paths and/or shorter adhesive paths may use fewer vacuum ports and/or adhesive ports.
In an aspect, the adhesive path 304 may be pulled to a vacuum (e.g., a near vacuum, or a decreased pressure relative to ambient pressure). Adhesive may then be added to the adhesive path 304. In an aspect, an adhesive path 304 may take as long to fill as the longest single path in the adhesive path 304, e.g., for equal volume rates for each adhesive port with each path having the same vacuum level.
Other aspects may use adhesive injection pressure, e.g., without a vacuum. In such an aspect, the pressure of the adhesive may expel air in the adhesive path 304 as the air is expelled from the adhesive path 304. The adhesive may be applied under pressure until adhesive flows out from weep holes, e.g., a hole or holes in an adhesive path that may generally be near the end of the adhesive path and configured to allow air to escape the adhesive path 304 as adhesive is added to the adhesive path 304 and allow adhesive to “weep” out of the hole when the adhesive path 304 is filled with adhesive. The weep holes may provide a visual indication that an adhesive path 304 has been filed with adhesive. Another aspect may use a foaming adhesive. The foaming adhesive may be activated by heating. The foaming adhesive may fill the adhesive path 304 and the adhesive path 304 may be heated to activate the foaming or the foaming adhesive to improve the bonding to the metal. Other aspects may use adhesive injection pressure and a vacuum.
An aspect may include features such as standoffs between sub-components. The standoffs may prevent contact between dissimilar materials of the sub-components. Accordingly, the standoffs may prevent galvanic corrosion. In an aspect, clamping may be used to connect sub-components to the standoff. Other aspects to prevent galvanic corrosion will be apparent to persons skilled in the art.
An aspect may be an apparatus that includes an additively manufactured component (e.g., printed nodes 204) having an adhesive injection channel (e.g., adhesive path 304) and an adhesive flow mechanism including at least one of an adhesive side end effector or a vacuum side end effector (e.g., the adhesive port 306a or 306b). The adhesive flow mechanism may be configured to provide adhesive to the adhesive injection channels (e.g., adhesive path 304).
In an aspect, adhesive may be introduced to the subassembly or assembly (e.g., the node 408) using a sequential process. Acceptor features may be included with the additively manufactured nodes 408. The nodes 408 may be connected to other nodes (not shown), extrusions, tubes, castings, or other components that may be connected to a node. The node 408 may be adhesively bonded to the other component(s). The acceptor features may include a boss with two recesses, e.g., one for receiving a tip of the adhesive side of the end effector 402 and one for receiving a tip of the vacuum side of the end effector 404. The boss may serve as a reference for the end effector to enable automated assembly of transport structures comprising additively manufactured nodes 408 and the aforementioned components, e.g., other nodes, extrusions, tubes, castings, or other components that may be connected to a node.
In an aspect, the adhesive injection process may be broken down into three steps (1) drawing the vacuum, (2) injecting the adhesive, (3) sealing the adhesive and vacuum ports on the node.
At block 604, additively manufacturing the second component. In an aspect, the second component may be additively manufactured. In another aspect, the second component may be a commercial off the shelf product.
In an aspect, additively manufacturing the component (e.g., node 204) may include forming a vacuum channel (e.g., adhesive injection channel 302) in the node 204 for providing a vacuum to the area between the components when the second component (e.g., another node 204) is being connected to the component (e.g., node 204). In an aspect, additively manufacturing the component may include forming the area in a shape suitable for receiving the second component. In another example, the second component may be a tube, e.g., a printed or extruded tube as described above. In an aspect, additively manufacturing the component may include forming an area in a shape suitable to receive the second component (e.g., node 204). In another example, the second component may be a panel 206.
In block 704, the components may be assembled such that adhesive injection channels align to form an adhesive path that allows adhesive flow between the components. For example, the components may be assembled such that adhesive injection channels (e.g., adhesive injection channel 302) align to form an adhesive path 304 that allows adhesive flow between the components.
In an aspect, additively manufacturing the components (e.g., printed nodes 204) may include forming one of the components with an adhesive port 306a, 306b for injecting adhesive into the adhesive path 304. An aspect relates to injecting adhesive through the adhesive port 306a, 306b into the adhesive path 304 to adhere the components (e.g., printed nodes 204, panel 206, extrusions 208) together. In an aspect, the additively manufacturing of the component (e.g., printed nodes 204) includes forming a vacuum channel in each of the components, and assembling the components includes aligning the vacuum channels (e.g., adhesive injection channel 302) to form a vacuum path (e.g., adhesive path 304 or a dedicated vacuum path that may be connected or coupled to a vacuum) that allows a vacuum between the various components. The adhesive channels (e.g., adhesive injection channel 302) may extend from both the ports (e.g., adhesive port 306a, 306b) to complete an adhesive path loop or circuit.
In an aspect, additively manufacturing the components may include forming one of the components with a vacuum port (e.g., adhesive port 306a, 306b) for providing a vacuum to the vacuum path.
In an aspect, the components (e.g., printed nodes 204, panel 206, extrusions 208) may be assembled into a first subassembly. The method may further include assembling a second subassembly and a member having an adhesive injection channel 302. The method may include interconnecting the first and the second subassemblies via the member such that the adhesive injection channel 302 in the member connects the adhesive path 304 to the second subassembly. An aspect may include injecting adhesive through the adhesive path 304 and the adhesive injection channel 302 in the member into the second subassembly. In an aspect, additively manufacturing the components (e.g., printed nodes 204) may include forming one or more apertures in one or more of the components in communication with the adhesive path 304 to provide a visual indication of adhesive flow.
In an aspect, the assembling the components (e.g., printed nodes 204, panel 206, extrusions 208) may include using a first one of the components including a node 204 to connect a second one of the components (e.g., another node 204, panel 206, extrusions 208) to a third one of the components (e.g., panel 206, extrusions 208, and the like).
In an aspect, in place of additively manufacturing a second component, the second component may be a panel 206. In an aspect, the additively manufacturing of the components (e.g., printed nodes 204) may include forming the second one of the components into a tube (e.g., additively manufacturing a tube the size and shape of the extrusion 208).
In an aspect, any of the components as described above may be assembled into a subassembly for a vehicle. In an aspect, the components may be assembled into a subassembly for a vehicle chassis. Alternatively, the components (e.g., printed nodes 204, panel 206, extrusions 208) may be assembled into a subassembly for a vehicle body.
In block 804, the first components may be assembled into a first subassembly with the adhesive injection channels aligned to form a first adhesive path that allows adhesive flow between the first components. For example, the first components, such as nodes 204, may be assembled into a first subassembly with the adhesive injection channels (302) aligned to form a first adhesive path (304) that allows adhesive flow between the first components (nodes 204).
In block 806, a plurality of second components may be additively manufactured, each of the second components having an adhesive injection channel. These second components may, for example, include nodes 204 such that each of the second components (nodes 204) has an adhesive injection channel (302).
In block 808, the second components may be assembled into a second subassembly with the adhesive injection channels aligned to form a second adhesive path that allows adhesive flow between the second components. For example, the second components may include nodes 204 and may be assembled into a second subassembly with the adhesive injection channels (302) aligned to form a second adhesive path (304) that allows adhesive flow between the second components, such as additional nodes 204.
In block 810, the subassemblies may be connected with the first adhesive path (304) aligned with the second adhesive path (304) to allow adhesive to flow between the first and second subassemblies. For example, the subassemblies may be connected with the first adhesive path (304) aligned with the second adhesive path (304) to allow adhesive to flow between the first and second subassemblies.
The previous description is provided to enable any person skilled in the art to practice the various aspects described herein. Various modifications to these exemplary embodiments presented throughout this disclosure will be readily apparent to those skilled in the art, and the concepts disclosed herein may be applied to using adhesives with 3-D printed components. Thus, the claims are not intended to be limited to the exemplary embodiments presented throughout the disclosure but are to be accorded the full scope consistent with the language claims. All structural and functional equivalents to the elements of the exemplary embodiments described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are intended to be encompassed by the claims. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the claims. No claim element is to be construed under the provisions of 35 U.S.C. § 112(f), or analogous law in applicable jurisdictions, unless the element is expressly recited using the phrase “means for” or, in the case of a method claim, the element is recited using the phrase “step for.”
Number | Name | Date | Kind |
---|---|---|---|
4721407 | Liu | Jan 1988 | A |
5203226 | Hongou et al. | Apr 1993 | A |
5742385 | Champa | Apr 1998 | A |
5990444 | Costin | Nov 1999 | A |
6010155 | Rinehart | Jan 2000 | A |
6096249 | Yamaguchi | Aug 2000 | A |
6140602 | Costin | Oct 2000 | A |
6250533 | Otterbein et al. | Jun 2001 | B1 |
6252196 | Costin et al. | Jun 2001 | B1 |
6318642 | Goenka et al. | Nov 2001 | B1 |
6365057 | Whitehurst et al. | Apr 2002 | B1 |
6391251 | Keicher et al. | May 2002 | B1 |
6409930 | Whitehurst et al. | Jun 2002 | B1 |
6468439 | Whitehurst et al. | Oct 2002 | B1 |
6554345 | Jonsson | Apr 2003 | B2 |
6585151 | Ghosh | Jul 2003 | B1 |
6644721 | Miskech et al. | Nov 2003 | B1 |
6811744 | Keicher et al. | Nov 2004 | B2 |
6866497 | Saiki | Mar 2005 | B2 |
6919035 | Clough | Jul 2005 | B1 |
6926970 | James et al. | Aug 2005 | B2 |
7152292 | Hohmann et al. | Dec 2006 | B2 |
7344186 | Hausler et al. | Mar 2008 | B1 |
7500373 | Quell | Mar 2009 | B2 |
7586062 | Heberer | Sep 2009 | B2 |
7637134 | Burzlaff et al. | Dec 2009 | B2 |
7710347 | Gentilman et al. | May 2010 | B2 |
7716802 | Stern et al. | May 2010 | B2 |
7745293 | Yamazaki et al. | Jun 2010 | B2 |
7766123 | Sakurai et al. | Aug 2010 | B2 |
7852388 | Shimizu et al. | Dec 2010 | B2 |
7908922 | Zarabadi et al. | Mar 2011 | B2 |
7951324 | Naruse et al. | May 2011 | B2 |
8094036 | Heberer | Jan 2012 | B2 |
8163077 | Eron et al. | Apr 2012 | B2 |
8286236 | Jung et al. | Oct 2012 | B2 |
8289352 | Vartanian et al. | Oct 2012 | B2 |
8297096 | Mizumura et al. | Oct 2012 | B2 |
8354170 | Henry et al. | Jan 2013 | B1 |
8383028 | Lyons | Feb 2013 | B2 |
8408036 | Reith et al. | Apr 2013 | B2 |
8412367 | Mahaffy | Apr 2013 | B2 |
8429754 | Jung et al. | Apr 2013 | B2 |
8437513 | Derakhshani et al. | May 2013 | B1 |
8444903 | Lyons et al. | May 2013 | B2 |
8452073 | Taminger et al. | May 2013 | B2 |
8599301 | Dowski, Jr. et al. | Dec 2013 | B2 |
8606540 | Haisty et al. | Dec 2013 | B2 |
8610761 | Haisty et al. | Dec 2013 | B2 |
8631996 | Quell et al. | Jan 2014 | B2 |
8675925 | Derakhshani et al. | Mar 2014 | B2 |
8678060 | Dietz et al. | Mar 2014 | B2 |
8686314 | Schneegans et al. | Apr 2014 | B2 |
8686997 | Radet et al. | Apr 2014 | B2 |
8694284 | Berard | Apr 2014 | B2 |
8720876 | Reith et al. | May 2014 | B2 |
8752166 | Jung et al. | Jun 2014 | B2 |
8755923 | Farahani et al. | Jun 2014 | B2 |
8787628 | Derakhshani et al. | Jul 2014 | B1 |
8818771 | Gielis et al. | Aug 2014 | B2 |
8873238 | Wilkins | Oct 2014 | B2 |
8978535 | Ortiz et al. | Mar 2015 | B2 |
9006605 | Schneegans et al. | Apr 2015 | B2 |
9071436 | Jung et al. | Jun 2015 | B2 |
9101979 | Hofmann et al. | Aug 2015 | B2 |
9104921 | Derakhshani et al. | Aug 2015 | B2 |
9126365 | Mark et al. | Sep 2015 | B1 |
9128476 | Jung et al. | Sep 2015 | B2 |
9138924 | Yen | Sep 2015 | B2 |
9149988 | Mark et al. | Oct 2015 | B2 |
9156205 | Mark et al. | Oct 2015 | B2 |
9186848 | Mark et al. | Nov 2015 | B2 |
9244986 | Karmarkar | Jan 2016 | B2 |
9248611 | Divine et al. | Feb 2016 | B2 |
9254535 | Buller et al. | Feb 2016 | B2 |
9266566 | Kim | Feb 2016 | B2 |
9269022 | Rhoads et al. | Feb 2016 | B2 |
9327452 | Mark et al. | May 2016 | B2 |
9329020 | Napoletano | May 2016 | B1 |
9332251 | Haisty et al. | May 2016 | B2 |
9346127 | Buller et al. | May 2016 | B2 |
9389315 | Bruder et al. | Jul 2016 | B2 |
9399256 | Buller et al. | Jul 2016 | B2 |
9403235 | Buller et al. | Aug 2016 | B2 |
9418193 | Dowski, Jr. et al. | Aug 2016 | B2 |
9457514 | Schwärzler | Oct 2016 | B2 |
9469057 | Johnson et al. | Oct 2016 | B2 |
9478063 | Rhoads et al. | Oct 2016 | B2 |
9481402 | Muto et al. | Nov 2016 | B1 |
9486878 | Buller et al. | Nov 2016 | B2 |
9486960 | Paschkewitz et al. | Nov 2016 | B2 |
9502993 | Deng | Nov 2016 | B2 |
9525262 | Stuart et al. | Dec 2016 | B2 |
9533526 | Nevins | Jan 2017 | B1 |
9555315 | Aders | Jan 2017 | B2 |
9555580 | Dykstra et al. | Jan 2017 | B1 |
9557856 | Send et al. | Jan 2017 | B2 |
9566742 | Keating et al. | Feb 2017 | B2 |
9566758 | Cheung et al. | Feb 2017 | B2 |
9567013 | Erlich et al. | Feb 2017 | B2 |
9573193 | Buller et al. | Feb 2017 | B2 |
9573225 | Buller et al. | Feb 2017 | B2 |
9586290 | Buller et al. | Mar 2017 | B2 |
9595795 | Lane et al. | Mar 2017 | B2 |
9597843 | Stauffer et al. | Mar 2017 | B2 |
9600929 | Young et al. | Mar 2017 | B1 |
9609755 | Coull et al. | Mar 2017 | B2 |
9610737 | Johnson et al. | Apr 2017 | B2 |
9611667 | GangaRao et al. | Apr 2017 | B2 |
9616623 | Johnson et al. | Apr 2017 | B2 |
9626487 | Jung et al. | Apr 2017 | B2 |
9626489 | Nilsson | Apr 2017 | B2 |
9643361 | Liu | May 2017 | B2 |
9662840 | Buller et al. | May 2017 | B1 |
9665182 | Send et al. | May 2017 | B2 |
9672389 | Mosterman et al. | Jun 2017 | B1 |
9672550 | Apsley et al. | Jun 2017 | B2 |
9676145 | Buller et al. | Jun 2017 | B2 |
9684919 | Apsley et al. | Jun 2017 | B2 |
9688032 | Kia et al. | Jun 2017 | B2 |
9690286 | Hovsepian et al. | Jun 2017 | B2 |
9700966 | Kraft et al. | Jul 2017 | B2 |
9703896 | Zhang et al. | Jul 2017 | B2 |
9713903 | Paschkewitz et al. | Jul 2017 | B2 |
9718302 | Young et al. | Aug 2017 | B2 |
9718434 | Hector, Jr. et al. | Aug 2017 | B2 |
9724877 | Flitsch et al. | Aug 2017 | B2 |
9724881 | Johnson et al. | Aug 2017 | B2 |
9725178 | Wang | Aug 2017 | B2 |
9731730 | Stiles | Aug 2017 | B2 |
9731773 | Garni et al. | Aug 2017 | B2 |
9741954 | Bruder et al. | Aug 2017 | B2 |
9747352 | Karmarkar | Aug 2017 | B2 |
9764415 | Seufzer et al. | Sep 2017 | B2 |
9764520 | Johnson et al. | Sep 2017 | B2 |
9765226 | Dain | Sep 2017 | B2 |
9770760 | Liu | Sep 2017 | B2 |
9773393 | Velez | Sep 2017 | B2 |
9776234 | Schaafhausen et al. | Oct 2017 | B2 |
9782936 | Glunz et al. | Oct 2017 | B2 |
9783324 | Embler et al. | Oct 2017 | B2 |
9783977 | Alqasimi et al. | Oct 2017 | B2 |
9789548 | Golshany et al. | Oct 2017 | B2 |
9789922 | Dosenbach et al. | Oct 2017 | B2 |
9796137 | Zhang et al. | Oct 2017 | B2 |
9802108 | Aders | Oct 2017 | B2 |
9809977 | Carney et al. | Nov 2017 | B2 |
9817922 | Glunz et al. | Nov 2017 | B2 |
9818071 | Jung et al. | Nov 2017 | B2 |
9821339 | Paschkewitz et al. | Nov 2017 | B2 |
9821411 | Buller et al. | Nov 2017 | B2 |
9823143 | Twelves, Jr. et al. | Nov 2017 | B2 |
9829564 | Bruder et al. | Nov 2017 | B2 |
9846933 | Yuksel | Dec 2017 | B2 |
9854828 | Langeland | Jan 2018 | B2 |
9858604 | Apsley et al. | Jan 2018 | B2 |
9862833 | Hasegawa et al. | Jan 2018 | B2 |
9862834 | Hasegawa et al. | Jan 2018 | B2 |
9863885 | Zaretski et al. | Jan 2018 | B2 |
9870629 | Cardno et al. | Jan 2018 | B2 |
9879981 | Dehghan Niri et al. | Jan 2018 | B1 |
9884663 | Czinger et al. | Feb 2018 | B2 |
9898776 | Apsley et al. | Feb 2018 | B2 |
9914150 | Pettersson et al. | Mar 2018 | B2 |
9919360 | Buller et al. | Mar 2018 | B2 |
9931697 | Levin et al. | Apr 2018 | B2 |
9933031 | Bracamonte et al. | Apr 2018 | B2 |
9933092 | Sindelar | Apr 2018 | B2 |
9957031 | Golshany et al. | May 2018 | B2 |
9958535 | Send et al. | May 2018 | B2 |
9962767 | Buller et al. | May 2018 | B2 |
9963978 | Johnson et al. | May 2018 | B2 |
9971920 | Derakhshani et al. | May 2018 | B2 |
9976063 | Childers et al. | May 2018 | B2 |
9987792 | Flitsch et al. | Jun 2018 | B2 |
9988136 | Tiryaki et al. | Jun 2018 | B2 |
9989623 | Send et al. | Jun 2018 | B2 |
9990565 | Rhoads et al. | Jun 2018 | B2 |
9994339 | Colson et al. | Jun 2018 | B2 |
9996890 | Cinnamon et al. | Jun 2018 | B1 |
9996945 | Holzer et al. | Jun 2018 | B1 |
10002215 | Dowski et al. | Jun 2018 | B2 |
10006156 | Kirkpatrick | Jun 2018 | B2 |
10011089 | Lyons et al. | Jul 2018 | B2 |
10011685 | Childers et al. | Jul 2018 | B2 |
10012532 | Send et al. | Jul 2018 | B2 |
10013777 | Mariampillai et al. | Jul 2018 | B2 |
10015908 | Williams et al. | Jul 2018 | B2 |
10016852 | Broda | Jul 2018 | B2 |
10016942 | Mark et al. | Jul 2018 | B2 |
10017384 | Greer et al. | Jul 2018 | B1 |
10018576 | Herbsommer et al. | Jul 2018 | B2 |
10022792 | Srivas et al. | Jul 2018 | B2 |
10022912 | Kia et al. | Jul 2018 | B2 |
10027376 | Sankaran et al. | Jul 2018 | B2 |
10029415 | Swanson et al. | Jul 2018 | B2 |
10040239 | Brown, Jr. | Aug 2018 | B2 |
10046412 | Blackmore | Aug 2018 | B2 |
10048769 | Selker et al. | Aug 2018 | B2 |
10052712 | Blackmore | Aug 2018 | B2 |
10052820 | Kemmer et al. | Aug 2018 | B2 |
10055536 | Maes et al. | Aug 2018 | B2 |
10058764 | Aders | Aug 2018 | B2 |
10058920 | Buller et al. | Aug 2018 | B2 |
10061906 | Nilsson | Aug 2018 | B2 |
10065270 | Buller et al. | Sep 2018 | B2 |
10065361 | Susnjara et al. | Sep 2018 | B2 |
10065367 | Brown, Jr. | Sep 2018 | B2 |
10068316 | Holzer et al. | Sep 2018 | B1 |
10071422 | Buller et al. | Sep 2018 | B2 |
10071525 | Susnjara et al. | Sep 2018 | B2 |
10072179 | Drijfhout | Sep 2018 | B2 |
10074128 | Colson et al. | Sep 2018 | B2 |
10076875 | Mark et al. | Sep 2018 | B2 |
10076876 | Mark et al. | Sep 2018 | B2 |
10081140 | Paesano et al. | Sep 2018 | B2 |
10081431 | Seack et al. | Sep 2018 | B2 |
10086568 | Snyder et al. | Oct 2018 | B2 |
10087320 | Simmons et al. | Oct 2018 | B2 |
10087556 | Gallucci et al. | Oct 2018 | B2 |
10099427 | Mark et al. | Oct 2018 | B2 |
10100542 | GangaRao et al. | Oct 2018 | B2 |
10100890 | Bracamonte et al. | Oct 2018 | B2 |
10107344 | Bracamonte et al. | Oct 2018 | B2 |
10108766 | Druckman et al. | Oct 2018 | B2 |
10113600 | Bracamonte et al. | Oct 2018 | B2 |
10118347 | Stauffer et al. | Nov 2018 | B2 |
10118579 | Lakic | Nov 2018 | B2 |
10120078 | Bruder et al. | Nov 2018 | B2 |
10124546 | Johnson et al. | Nov 2018 | B2 |
10124570 | Evans et al. | Nov 2018 | B2 |
10137500 | Blackmore | Nov 2018 | B2 |
10138354 | Groos et al. | Nov 2018 | B2 |
10144126 | Krohne et al. | Dec 2018 | B2 |
10145110 | Carney et al. | Dec 2018 | B2 |
10151363 | Bracamonte et al. | Dec 2018 | B2 |
10152661 | Kieser | Dec 2018 | B2 |
10160278 | Coombs et al. | Dec 2018 | B2 |
10161021 | Lin et al. | Dec 2018 | B2 |
10166752 | Evans et al. | Jan 2019 | B2 |
10166753 | Evans et al. | Jan 2019 | B2 |
10171578 | Cook et al. | Jan 2019 | B1 |
10173255 | TenHouten et al. | Jan 2019 | B2 |
10173327 | Kraft et al. | Jan 2019 | B2 |
10178800 | Mahalingam et al. | Jan 2019 | B2 |
10179640 | Wilkerson | Jan 2019 | B2 |
10183330 | Buller et al. | Jan 2019 | B2 |
10183478 | Evans et al. | Jan 2019 | B2 |
10189187 | Keating et al. | Jan 2019 | B2 |
10189240 | Evans et al. | Jan 2019 | B2 |
10189241 | Evans et al. | Jan 2019 | B2 |
10189242 | Evans et al. | Jan 2019 | B2 |
10190424 | Johnson et al. | Jan 2019 | B2 |
10195693 | Buller et al. | Feb 2019 | B2 |
10196539 | Boonen et al. | Feb 2019 | B2 |
10197338 | Melsheimer | Feb 2019 | B2 |
10200677 | Trevor et al. | Feb 2019 | B2 |
10201932 | Flitsch et al. | Feb 2019 | B2 |
10201941 | Evans et al. | Feb 2019 | B2 |
10202673 | Lin et al. | Feb 2019 | B2 |
10204216 | Nejati et al. | Feb 2019 | B2 |
10207454 | Buller et al. | Feb 2019 | B2 |
10209065 | Estevo, Jr. et al. | Feb 2019 | B2 |
10210662 | Holzer et al. | Feb 2019 | B2 |
10213837 | Kondoh | Feb 2019 | B2 |
10214248 | Hall et al. | Feb 2019 | B2 |
10214252 | Schellekens et al. | Feb 2019 | B2 |
10214275 | Goehlich | Feb 2019 | B2 |
10220575 | Reznar | Mar 2019 | B2 |
10220881 | Tyan et al. | Mar 2019 | B2 |
10221530 | Driskell et al. | Mar 2019 | B2 |
10226900 | Nevins | Mar 2019 | B1 |
10232550 | Evans et al. | Mar 2019 | B2 |
10234342 | Moorlag et al. | Mar 2019 | B2 |
10237477 | Trevor et al. | Mar 2019 | B2 |
10252335 | Buller et al. | Apr 2019 | B2 |
10252336 | Buller et al. | Apr 2019 | B2 |
10254499 | Cohen et al. | Apr 2019 | B1 |
10257499 | Hintz et al. | Apr 2019 | B2 |
10259044 | Buller et al. | Apr 2019 | B2 |
10268181 | Nevins | Apr 2019 | B1 |
10269225 | Velez | Apr 2019 | B2 |
10272860 | Mohapatra et al. | Apr 2019 | B2 |
10272862 | Whitehead | Apr 2019 | B2 |
10275564 | Ridgeway et al. | Apr 2019 | B2 |
10279580 | Evans et al. | May 2019 | B2 |
10285219 | Fetfatsidis et al. | May 2019 | B2 |
10286452 | Buller et al. | May 2019 | B2 |
10286603 | Buller et al. | May 2019 | B2 |
10286961 | Hillebrecht et al. | May 2019 | B2 |
10289263 | Troy et al. | May 2019 | B2 |
10289875 | Singh et al. | May 2019 | B2 |
10291193 | Dandu et al. | May 2019 | B2 |
10294552 | Liu et al. | May 2019 | B2 |
10294982 | Gabrys et al. | May 2019 | B2 |
10295989 | Nevins | May 2019 | B1 |
10303159 | Czinger et al. | May 2019 | B2 |
10307824 | Kondoh | Jun 2019 | B2 |
10310197 | Droz et al. | Jun 2019 | B1 |
10313651 | Trevor et al. | Jun 2019 | B2 |
10315252 | Mendelsberg et al. | Jun 2019 | B2 |
10336050 | Susnjara | Jul 2019 | B2 |
10337542 | Hesslewood et al. | Jul 2019 | B2 |
10337952 | Bosetti et al. | Jul 2019 | B2 |
10339266 | Urick et al. | Jul 2019 | B2 |
10343330 | Evans et al. | Jul 2019 | B2 |
10343331 | McCall et al. | Jul 2019 | B2 |
10343355 | Evans et al. | Jul 2019 | B2 |
10343724 | Polewarczyk et al. | Jul 2019 | B2 |
10343725 | Martin et al. | Jul 2019 | B2 |
10350823 | Rolland et al. | Jul 2019 | B2 |
10356341 | Holzer et al. | Jul 2019 | B2 |
10356395 | Holzer et al. | Jul 2019 | B2 |
10357829 | Spink et al. | Jul 2019 | B2 |
10357957 | Buller et al. | Jul 2019 | B2 |
10359756 | Newell et al. | Jul 2019 | B2 |
10369629 | Mendelsberg et al. | Aug 2019 | B2 |
10382739 | Rusu et al. | Aug 2019 | B1 |
10384393 | Xu et al. | Aug 2019 | B2 |
10384416 | Cheung et al. | Aug 2019 | B2 |
10389410 | Brooks et al. | Aug 2019 | B2 |
10391710 | Mondesir | Aug 2019 | B2 |
10392097 | Pham et al. | Aug 2019 | B2 |
10392131 | Deck et al. | Aug 2019 | B2 |
10393315 | Tyan | Aug 2019 | B2 |
10400080 | Ramakrishnan et al. | Sep 2019 | B2 |
10401832 | Snyder et al. | Sep 2019 | B2 |
10403009 | Mariampillai et al. | Sep 2019 | B2 |
10406750 | Barton et al. | Sep 2019 | B2 |
10412283 | Send et al. | Sep 2019 | B2 |
10416095 | Herbsommer et al. | Sep 2019 | B2 |
10421496 | Swayne et al. | Sep 2019 | B2 |
10421863 | Hasegawa et al. | Sep 2019 | B2 |
10422478 | Leachman et al. | Sep 2019 | B2 |
10425793 | Sankaran et al. | Sep 2019 | B2 |
10427364 | Alves | Oct 2019 | B2 |
10429006 | Tyan et al. | Oct 2019 | B2 |
10434573 | Buller et al. | Oct 2019 | B2 |
10435185 | Divine et al. | Oct 2019 | B2 |
10435773 | Liu et al. | Oct 2019 | B2 |
10436038 | Buhler et al. | Oct 2019 | B2 |
10438407 | Pavanaskar et al. | Oct 2019 | B2 |
10440351 | Holzer et al. | Oct 2019 | B2 |
10442002 | Benthien et al. | Oct 2019 | B2 |
10442003 | Symeonidis et al. | Oct 2019 | B2 |
10449696 | Elgar et al. | Oct 2019 | B2 |
10449737 | Johnson et al. | Oct 2019 | B2 |
10461810 | Cook et al. | Oct 2019 | B2 |
20060096224 | Asbury | May 2006 | A1 |
20060108783 | Ni et al. | May 2006 | A1 |
20070261787 | Malis | Nov 2007 | A1 |
20070270029 | Schroeder et al. | Nov 2007 | A1 |
20110158741 | Knaebel | Jun 2011 | A1 |
20140241790 | Woleader et al. | Aug 2014 | A1 |
20140277669 | Nardi et al. | Sep 2014 | A1 |
20140301775 | Erlich et al. | Oct 2014 | A1 |
20160016229 | Czinger et al. | Jan 2016 | A1 |
20160325796 | Czinger | Nov 2016 | A1 |
20170057558 | Hillebrecht et al. | Mar 2017 | A1 |
20170113344 | Schonberg | Apr 2017 | A1 |
20170341309 | Piepenbrock et al. | Nov 2017 | A1 |
Number | Date | Country |
---|---|---|
201620105052 | Apr 2017 | DE |
0450358 | Oct 1991 | EP |
15182959.5 | Aug 2015 | EP |
1996036455 | Nov 1996 | WO |
1996036525 | Nov 1996 | WO |
1996038260 | Dec 1996 | WO |
2003024641 | Mar 2003 | WO |
2004108343 | Dec 2004 | WO |
2005093773 | Oct 2005 | WO |
2007003375 | Jan 2007 | WO |
2007110235 | Oct 2007 | WO |
2007110236 | Oct 2007 | WO |
2008019847 | Feb 2008 | WO |
2007128586 | Jun 2008 | WO |
2008068314 | Jun 2008 | WO |
2008086994 | Jul 2008 | WO |
2008087024 | Jul 2008 | WO |
2008107130 | Sep 2008 | WO |
2008138503 | Nov 2008 | WO |
2008145396 | Dec 2008 | WO |
2009083609 | Jul 2009 | WO |
2009098285 | Aug 2009 | WO |
2009112520 | Sep 2009 | WO |
2009135938 | Nov 2009 | WO |
2009140977 | Nov 2009 | WO |
2010125057 | Nov 2010 | WO |
2010125058 | Nov 2010 | WO |
2010142703 | Dec 2010 | WO |
2011032533 | Mar 2011 | WO |
2014016437 | Jan 2014 | WO |
2014187720 | Nov 2014 | WO |
2014195340 | Dec 2014 | WO |
2015193331 | Dec 2015 | WO |
2016116414 | Jul 2016 | WO |
2017036461 | Mar 2017 | WO |
2019030248 | Feb 2019 | WO |
2019042504 | Mar 2019 | WO |
2019048010 | Mar 2019 | WO |
2019048498 | Mar 2019 | WO |
2019048680 | Mar 2019 | WO |
2019048682 | Mar 2019 | WO |
Entry |
---|
US 9,809,265 B2, 11/2017, Kinjo (withdrawn) |
International Search Report and Written Opinion dated Mar. 26, 2019, regarding PCT/US2018/065008. |
Number | Date | Country | |
---|---|---|---|
20190193163 A1 | Jun 2019 | US |